Modulation of telomere length in telomerase positive cells...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/522 (2006.01) A61K 31/7072 (2006.01) A61K 31/708 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2602562

Induction of telomere shortening, G2 arrest and apoptosis in telomerase positive cancer cells using acyclic nucleoside analogs has been disclosed. In addition, methods for impairment or prevention of tumorigenic telomerase positive cells from having a chance to grow into a tumor and methods for promoting tumor regression (decrease in size of an established tumor) using acyclic nucleoside analogs has been disclosed.

L'invention concerne l'induction d'un raccourcissement des télomères, d'un arrêt de la phase G2 et d'une apoptose dans des cellules cancéreuses télomérase positives à l'aide d'analogues de nucléosides acyliques. En outre, l'invention concerne des méthodes destinées à altérer ou à empêcher la possibilité pour des cellules tumorigènes télomérase positives de présenter une chance de se développer dans une tumeur ainsi que des méthodes destinées à favoriser une régression tumorale (diminution de taille d'une tumeur établie) à l'aide d'analogues de nucléosides acyliques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulation of telomere length in telomerase positive cells... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of telomere length in telomerase positive cells..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of telomere length in telomerase positive cells... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1393643

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.